Tissue Sterilization Process Proven Effective

More than 540,000 implants sterilized with a patented tissue sterilization process called BioCleanse have been distributed with no incidence of graft-related infection.

Standard methods to prepare tissue for transplant include screening for diseases, bacterial testing, and aseptic processing, all of which help to reduce the risk to patients but are not sufficient to eliminate the risk of allograft-associated infections in recipients. The BioCleanse method, developed and patented by Regeneration Technologies, Inc. (RTI, Alachua, FL, USA), is a proven tissue sterilization process, validated to eliminate viruses, bacteria, fungi, and spores from tissue without affecting the structural biomechanical integrity of the allograft.

RTI processes allograft tissue into shaped implants for use in orthopedic, cardiovascular, and other surgeries, enabling patients to benefit from the gift of donated tissues. "Donor families entrust us with their gift of donation because they know through our innovations, we will serve as responsible stewards of each gift by safely helping as many people as possible,” remarked Brian K. Hutchison, chairman, president, and CEO of RTI. The company was named a 2004 Technology Pioneer by the World Economic Forum.




Related Links:
RTI